Issue 2/1997
Content (15 Articles)
Chronic myelomonocytic leukemia: from biology to therapy
N. Cambier, A. Baruchel, M. H. Schlageter, M. L. Menot, E. Wattel, P. Fenaux, C. Chomienne
The ex vivo expansion capacity of normal human bone marrow cellsis dependent on experimental conditions: role of the cell concentration, serum and CD34+ cell selection in stroma-free cultures
A. Poloni, M. C. Giarratana, H. Firat, L. Kobari, N. C. Gorin, L. Douay
Results of three courses of adriamycin, bleomycin, vindesine, and dacarbazine with subtotal nodal irradiation in 189 patients with nodal Hodgkin’s disease (stage I, II and IIIA)
M. André, P. Brice, D. Cazals, C. Hennequin, C. Fermé, Y. Kerneis, P. Rousselot, J. M. Zini, E. Lepage, C. Gisselbrecht
Comparison of T cell depletion strategies from bone marrow, umbilical cord and peripheral blood using five separation systems
P. Feugier, S. Thévenin, M. Billot, B. Serrurier, C. Loigerot, F. Schooneman, C. Janot, P. Hervé, E. Racadot
Expression of CD95(Fas) by gene transfer does not sensitize K562 to Fas-killing
R. Munker, F. Marini, S. Jiang, C. Savary, L. Owen-Schaub, M. Andreeff
High-dose chemotherapy and autologous hematopoieticstem cell transplantation in patients with second primary malignancies
S. Fetscher, J. Finke, R. Engelhardt, R. Mertelsmann, W. Lange
Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF
E. Gautier, J. H. Bourhis, C. Bayle, J. Cartron, J. L. Pico, G. Tchernia
Listeriosis after fludarabine treatment for chronic lymphocytic leukemia
O. Hequet, J. P. de Jaureguiberry, D. Jaubert, O. Gisserot, Y. Muzellec, P. Brisou
Thérapie génique du déficit immunitaire combiné sévère lié à LX
A. Fischer
Suppression or overexpression of genes encoding myeloid growth factors or their receptors
D. Metcalf
Pathophysiology of Kostmann syndrome: the G-CSF receptor issue
J. Donadieu
The use of cytokines in the treatment of solid tumours
W. H. Fridman, E. Tartour
Gène de l’érythropoïétine : régulation et intérêt thérapeutique
B. Dalle, P. Rouyer-Fessard, A. Henri, Y. Beuzard
C-kit mutations and mast cell disorders A model of activating mutations of growth factor receptors
J.-M. Pignon
Dysregulated Mpl-Ligand production by hemopoietic cellsinduces a fatal myeloproliferative syndrome in mice
J.-L. Villeval, K. Cohen-Solal, M. Tulliez, S. Giraudier, J. Guichard, S. Burstein, E. M. Cramer, W. Vainchenker, F. Wendling